Skip to Main Content

Skip Nav Destination

Article navigation

Articles| March 01 1954

Metabolic Studies on the Effects of Crystalline Growth Hormone (Somatotropin) in Man

Ephraim Shorr, M.D;

Ephraim Shorr, M.D

The Russell Sage Institute of Pathology, the Department of Medicine, Cornell University Medical College and The New York Hospital

New York, N. Y.

Search for other works by this author on:

PubMed

Google Scholar

Anne C Carter, M.D;

Anne C Carter, M.D

The Russell Sage Institute of Pathology, the Department of Medicine, Cornell University Medical College and The New York Hospital

New York, N. Y.

Search for other works by this author on:

PubMed

Google Scholar

Byrl J Kennedy, M.D;

Byrl J Kennedy, M.D

The Russell Sage Institute of Pathology, the Department of Medicine, Cornell University Medical College and The New York Hospital

New York, N. Y.

Search for other works by this author on:

PubMed

Google Scholar

Richmond W Smith, Jr, M.D

Richmond W Smith, Jr, M.D

The Russell Sage Institute of Pathology, the Department of Medicine, Cornell University Medical College and The New York Hospital

New York, N. Y.

Search for other works by this author on:

PubMed

Google Scholar

Damon Runyon Fellow

Aided by a grant from the Playtex Park Research Institute.

We are indebted to the Armour Laboratories, Chicago, for the Somatotropin used in these studies.

Abridgment of paper presented, by special invitation, at the Joint Meeting of the American Diabetes Association and The Endocrine Society in New York on May 30, 1953.

Address communications to Dr. Shorr at the New York Hospital, 525 East 68th Street, New York 21, N. Y.

Diabetes 1954;3(2):94–98

https://doi.org/10.2337/diab.3.2.94